Jefferies Financial Group Forecasts Strong Price Appreciation for Alexandria Real Estate Equities (NYSE:ARE) Stock

Alexandria Real Estate Equities (NYSE:ARE) had its price objective upped by research analysts at Jefferies Financial Group from $47.00 to $57.00 in a report released on Friday,Benzinga reports. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. Jefferies Financial Group’s price target indicates a potential upside of 4.28% from the company’s previous close.

Other equities analysts have also issued research reports about the stock. Morgan Stanley began coverage on shares of Alexandria Real Estate Equities in a research report on Friday, January 9th. They set an “equal weight” rating and a $55.00 price objective for the company. Weiss Ratings restated a “sell (d)” rating on shares of Alexandria Real Estate Equities in a report on Wednesday, January 21st. Mizuho reduced their target price on Alexandria Real Estate Equities from $91.00 to $70.00 and set an “outperform” rating for the company in a report on Friday, January 9th. Cantor Fitzgerald lifted their price target on Alexandria Real Estate Equities from $46.00 to $60.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, BNP Paribas Exane cut their price objective on Alexandria Real Estate Equities from $72.00 to $50.00 and set an “underperform” rating on the stock in a report on Thursday, December 4th. Five research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Alexandria Real Estate Equities presently has an average rating of “Hold” and an average price target of $65.86.

Alexandria Real Estate Equities Trading Up 1.1%

Shares of ARE stock opened at $54.66 on Friday. The stock has a market cap of $9.47 billion, a P/E ratio of -6.48, a P/E/G ratio of 6.52 and a beta of 1.31. Alexandria Real Estate Equities has a fifty-two week low of $44.10 and a fifty-two week high of $105.14. The business has a fifty day simple moving average of $51.61 and a 200-day simple moving average of $66.57. The company has a quick ratio of 0.24, a current ratio of 0.23 and a debt-to-equity ratio of 0.65.

Alexandria Real Estate Equities (NYSE:ARE) last released its earnings results on Monday, January 26th. The real estate investment trust reported $2.16 EPS for the quarter, beating the consensus estimate of $2.15 by $0.01. Alexandria Real Estate Equities had a negative return on equity of 6.82% and a negative net margin of 47.23%.The firm had revenue of $754.41 million during the quarter, compared to analyst estimates of $742.64 million. During the same period in the prior year, the firm posted $2.39 earnings per share. The business’s quarterly revenue was down 4.4% compared to the same quarter last year. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts forecast that Alexandria Real Estate Equities will post 9.32 earnings per share for the current fiscal year.

Alexandria Real Estate Equities declared that its Board of Directors has authorized a stock repurchase plan on Monday, December 8th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the real estate investment trust to purchase up to 6.4% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its shares are undervalued.

Insider Transactions at Alexandria Real Estate Equities

In other Alexandria Real Estate Equities news, Director Sheila K. Mcgrath bought 3,100 shares of the business’s stock in a transaction on Wednesday, December 10th. The stock was purchased at an average price of $45.60 per share, for a total transaction of $141,360.00. Following the completion of the transaction, the director directly owned 8,392 shares of the company’s stock, valued at $382,675.20. This trade represents a 58.58% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.08% of the stock is owned by corporate insiders.

Institutional Trading of Alexandria Real Estate Equities

Institutional investors and hedge funds have recently bought and sold shares of the company. Norges Bank bought a new stake in Alexandria Real Estate Equities during the 2nd quarter valued at $1,195,306,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Alexandria Real Estate Equities by 1,022.1% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,813,955 shares of the real estate investment trust’s stock valued at $151,175,000 after purchasing an additional 1,652,298 shares during the period. DAVENPORT & Co LLC raised its position in Alexandria Real Estate Equities by 1,796.2% during the 2nd quarter. DAVENPORT & Co LLC now owns 835,789 shares of the real estate investment trust’s stock valued at $60,814,000 after purchasing an additional 791,712 shares during the last quarter. Menora Mivtachim Holdings LTD. bought a new position in Alexandria Real Estate Equities during the 3rd quarter valued at approximately $61,255,000. Finally, Lasalle Investment Management Securities LLC lifted its holdings in Alexandria Real Estate Equities by 89.2% in the 2nd quarter. Lasalle Investment Management Securities LLC now owns 1,175,406 shares of the real estate investment trust’s stock worth $85,370,000 after buying an additional 554,236 shares during the period. 96.54% of the stock is currently owned by hedge funds and other institutional investors.

More Alexandria Real Estate Equities News

Here are the key news stories impacting Alexandria Real Estate Equities this week:

• Positive Sentiment: Multiple brokerages raised price targets this week, signaling analyst confidence in recovery potential — Evercore bumped its target to $67 and kept an “outperform” rating. This is being read as bullish for upside expectations. Evercore price target raise
• Positive Sentiment: Cantor Fitzgerald raised its target to $60 (neutral rating), another upward revision that supports near-term upside vs. current levels. Cantor Fitzgerald price target raise
• Positive Sentiment: Jefferies raised its price target to $57 (hold), adding incremental support to the view that downside is limited from current levels. Jefferies price target raise
• Positive Sentiment: Quarterly earnings call highlighted stronger leasing activity in places and revenue slightly ahead of expectations, which investors view as evidence leasing fundamentals may stabilize. Q4 earnings call highlights
• Neutral Sentiment: Management is pursuing asset sales in the Bay Area (converting or selling life-sciences sites for housing), a move that can improve liquidity and de-lever the balance sheet but signals willingness to exit some life-sciences exposure. Bay Area site sales
• Neutral Sentiment: Company and brokers hold an average “Hold” recommendation, reflecting mixed views across the sell side — not a consensus buy but not a clear sell either. Brokerage consensus
• Negative Sentiment: Alexandria reported a roughly $1 billion loss tied to portfolio markdowns and non-cash items, and management warned of continued challenges in lab leasing — negatives that pressure near-term earnings visibility and NAV. $1B loss and lab glut
• Negative Sentiment: Plans were scrapped to convert a Fenway lab site to a different use, highlighting project-level pullbacks and execution changes amid weaker demand. Fenway conversion canceled
• Negative Sentiment: Coverage notes Alexandria underperformed peers recently, reflecting investor concern about exposure to a lab-glutted market and the company’s heavy leverage relative to peers. Underperformance vs peers

Alexandria Real Estate Equities Company Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.